排序方式: 共有24条查询结果,搜索用时 15 毫秒
1.
2.
3.
重型肝炎由于病情严重,发展迅速,临床死亡率较高,到目前为止尚无满意的治疗方法。国内从1988年开始探索,从乳猪新鲜肝脏制备具有促进肝细胞DNA合成的低分子量多肽类物质,命各为肝细胞生长素(Hepa-tocyte Growth Factor,HGF)。使重型肝炎尤其是慢性重型肝炎的治疗有了新的措施。我科自1990年开始试用HGF治疗慢性重型肝炎取得初步效果,现报道如下:1 材料与方法1.1 病例选择 治疗组21例中,早期病例9 相似文献
4.
5.
6.
7.
目的: 为研究脑型疟发病机制及防治提供理论依据。方法: 应用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳 (SDS-PAGE) 技术, 对云南省19 例脑型疟患者感染红细胞 (PE) 表达的红细胞膜蛋白1(PfEMP-1) 进行分析, 并分别与43 例恶性疟、9 例间日疟患者PE表达的PfEMP-1和PvEMP-1及6 例健康人红细胞膜蛋白(EMP) 进行比较。结果: 脑型疟患者PE存在高表达的高分子量PfEMP-1, 分子量为260~320 kDa。恶性疟及间日疟患者PE不表达260 kDa 以上的高分子量PfEMP-1,分别测到分子量最大为240kDa 的PfEMP-1和180 kDa的PvEMP-1。健康人对照组EMP分子量为140 kDa。结论: 脑型疟患者PE高表达的不同高分子量PfEMP-1 260~320 kDa, 与脑血管内皮细胞(EC) 不同受体蛋白CD36、血小板反应蛋白 (TSP)、细胞间粘附分子1 (ICAM-1)、血管细胞粘附分子1 (VCAM-1) 和内皮白细胞粘附分子1(ELAM-1) 及硫酸软骨素A (CSA) 的结合是脑型疟发病的分子基础, 可导致脑型疟患者发生昏迷。 相似文献
8.
脑型疟疾的微循环观察主要表现为管袢数目减少,口径挛缩,管袢周围有点状或片状渗血等从而提示脑型疟疾存在着血液流变学改变。我科于1989年5月至同年10月在云南省西双版纳地区勐腊县对6例脑型疟疾进行了血液流变学治疗前后的自身对照观察,取得了初步资料现报告如下: 相似文献
9.
Objective To approve a theoretical basis for the molecular pathogenesis of human cerebral malaria and treatment with prevention.Methods The blood samples were collected from 24 patients with cerebral malaria, 143 wit h falciparum malaria, 34 with vivax malaria and 20 healthy controls from the end emic areas of Yunnan Province, China. Using the sodium dodecyl sulfate-polya crylamide gel electrophoresis (SDS-PAGE) technique, we determined the molecular mass (Mr) of these Plasmodium falciparum (P. falciparum) erythrocyte membr ane protein 1 (PfEMP1) molecules. Results Our findings indicate that higher molecular mass (260 kDa-320 kDa) forms of Pf E MP1 were expressed on parasitized erythrocyte (PE) from human cerebral malaria p a tients. Compared with PfEMP1 expressed on PE from human cerebral malaria patien ts, the expression of PfEMP1 and Plasmodium vivax (P. vivax) erythrocyte me mbrane protein 1 (PvEMP1) on PE from falciparum malaria patients and vivax malar ia patients did not have multiple bands of PfEMP1 of ≥260 kDa, but had a PfEMP 1 with molecular mass of 240 kDa and a PvEMP1 with molecular mass of 180 kDa b and separately. Healthy controls expressed an EMP of molecular mass of 140 k Da.Conclusion Results confirm the antigenic variation of higher molecular mass of PfEMP1 whos e molecular mass is equal to or exceeds 260 kDa-320 kDa on PE of patients with cerebral malaria. Our results show that the binding of large antigenic variabi lity PfEMP1 molecular mass of 260 kDa-320 kDa on PE from human cerebral malari a patients with diverse receptor molecules on the endothelial cell (EC) of the c erebral microvessels may be involved in the molecular pathogenesis of cerebral m alaria. 相似文献
10.